ANIP · Company research
ANI Pharmaceuticals, Inc. (ANIP): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 71.52 | $1,621,710,000 | 1261498000 | 12.82077922077922 | — | 0.0668910220214568 | 6.0956458330201019 | 2.7154678740547745 | 30.2473188473374991 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.